Atlas Trials

Phase IIa Trial of a Selective Glucocorticoid Receptor Antagonist in the Treatment of Veterans With Posttraumatic Stress Disorder (PTSD) (Seven Study)

Clinical trial NCT04452500 · RECRUITING

Trial details

NCT number
NCT04452500
Sponsor
VA Office of Research and Development
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
PTSD
Start date
2022-10-15
Primary completion
2026-12-31
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.